• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组α1-抗胰蛋白酶注射液的物理稳定性

Physical stability of a recombinant alpha 1-antitrypsin injection.

作者信息

Yu C D, Roosdorp N, Pushpala S

机构信息

Cooper Laboratories Inc., Mountain View, California 94043.

出版信息

Pharm Res. 1988 Dec;5(12):800-2. doi: 10.1023/a:1015949004269.

DOI:10.1023/a:1015949004269
PMID:3266794
Abstract

Physical stability of a recombinant alpha 1-antitrypsin (rAAT) injection solution, namely, loss of rAAT to particulate formation was studied. The rAAT injection solution (1.0 mg/ml, pH 7.5, triple buffer of phosphate, Tris, and glycine, 0.075 M each) was filtered through a 0.2-micron filter and packaged in individual vials with rubber stoppers and aluminum seals. The vials were stored at 90, 80, 60, 45, 35, and 25 degrees C, and samples taken at predetermined time intervals for each storage condition. Each sample was then filtered through a 0.2-micron filter to remove particulates. The filtrate was then assayed for total protein by the biuret-phenol method. A typical first-order loss of rAAT was observed. Data were fitted to a first-order kinetics, and the shelf life (defined as t90, the time for the product to reach 90% remaining) was calculated from the resultant rate constant. The shelf lives were plotted against reciprocals of storage temperatures (a modified Arrhenius plot). A linear regression line (r = 0.9831) was drawn through the data points and extrapolated to 4 degrees C. At 4 degrees C, the predicted shelf life of the rAAT solution is 5.1 months. In real life, a batch of the rAAT solution showed that 61% of the rAAT remained in the filtrate after 18 months of storage at 4 degrees C. The observed stability compares fairly well with the predicted value of 69% for the same duration of storage at 4 degrees C. From the slope of the linear regression line, the activation energy for the particulate formation of the rAAT was calculated to be 19 kcal. This value is comparable to the activation energy of 20 kcal for ovalbumin denaturation reaction reported by Simpson and Kauzmann.

摘要

对重组α1-抗胰蛋白酶(rAAT)注射溶液的物理稳定性,即rAAT形成颗粒的损失情况进行了研究。将rAAT注射溶液(1.0 mg/ml,pH 7.5,由磷酸盐、Tris和甘氨酸组成的三重缓冲液,各0.075 M)通过0.2微米滤器过滤,并分装到带有橡胶塞和铝密封的单个小瓶中。将小瓶分别储存在90、80、60、45、35和25摄氏度下,并在每个储存条件下按预定时间间隔取样。然后将每个样品通过0.2微米滤器过滤以去除颗粒。接着用双缩脲-酚法测定滤液中的总蛋白。观察到rAAT呈现典型的一级损失。数据拟合为一级动力学,并根据所得速率常数计算保质期(定义为t90,即产品剩余90%的时间)。将保质期与储存温度的倒数作图(修正的阿仑尼乌斯图)。通过数据点绘制线性回归线(r = 0.9831)并外推至4摄氏度。在4摄氏度下,rAAT溶液的预测保质期为5.1个月。在实际情况中,一批rAAT溶液在4摄氏度储存18个月后,滤液中仍有61%的rAAT。观察到的稳定性与在4摄氏度相同储存时间下预测值69%相当。根据线性回归线的斜率,计算出rAAT形成颗粒的活化能为19千卡。该值与辛普森和考兹曼报道的卵清蛋白变性反应的20千卡活化能相当。

相似文献

1
Physical stability of a recombinant alpha 1-antitrypsin injection.重组α1-抗胰蛋白酶注射液的物理稳定性
Pharm Res. 1988 Dec;5(12):800-2. doi: 10.1023/a:1015949004269.
2
Effect of cryoprotectants on freezing, lyophilization, and storage of lyophilized recombinant alpha 1-antitrypsin formulations.冷冻保护剂对冻干重组α1-抗胰蛋白酶制剂的冷冻、冻干及储存的影响。
PDA J Pharm Sci Technol. 1994 Sep-Oct;48(5):241-6.
3
Fate of aerosolized recombinant DNA-produced alpha 1-antitrypsin: use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance.雾化重组DNA产生的α1-抗胰蛋白酶的命运:利用下呼吸道上皮表面来施用具有治疗重要性的蛋白质。
Proc Natl Acad Sci U S A. 1989 Jan;86(2):680-4. doi: 10.1073/pnas.86.2.680.
4
Production of functional human alpha 1-antitrypsin by plant cell culture.通过植物细胞培养生产功能性人α1-抗胰蛋白酶。
Appl Microbiol Biotechnol. 1999 Oct;52(4):516-23. doi: 10.1007/s002530051554.
5
Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency.通过气雾剂给药的重组DNA生产的α1-抗胰蛋白酶可增强α1-抗胰蛋白酶缺乏个体的下呼吸道抗中性粒细胞弹性蛋白酶防御能力。
J Clin Invest. 1989 Oct;84(4):1349-54. doi: 10.1172/JCI114305.
6
Bioreactor production of human alpha(1)-antitrypsin using metabolically regulated plant cell cultures.利用代谢调控的植物细胞培养物在生物反应器中生产人α1-抗胰蛋白酶。
Biotechnol Prog. 2002 May-Jun;18(3):501-8. doi: 10.1021/bp020299k.
7
Semicontinuous bioreactor production of a recombinant human therapeutic protein using a chemically inducible viral amplicon expression system in transgenic plant cell suspension cultures.利用化学诱导型病毒扩增子表达系统在转基因植物细胞悬浮培养物中半连续生物反应器生产重组人治疗蛋白。
Biotechnol Bioeng. 2010 Jun 15;106(3):408-21. doi: 10.1002/bit.22713.
8
rAAt (dermatological) Arriva/ProMetic.重组抗凝血酶(皮肤病学) 安进/普罗米特公司
Curr Opin Mol Ther. 2006 Feb;8(1):69-75.
9
Degradation kinetics of metronidazole in solution.甲硝唑在溶液中的降解动力学
J Pharm Sci. 1993 Jan;82(1):95-8. doi: 10.1002/jps.2600820121.
10
Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis.重组α1-抗胰蛋白酶疗法在囊性纤维化中的安全性和有效性。
Pediatr Pulmonol. 2006 Feb;41(2):177-83. doi: 10.1002/ppul.20345.

本文引用的文献

1
Heat lability of alpha1-antitrypsin variants.
Chest. 1973 Nov;64(5):579-84. doi: 10.1378/chest.64.5.579.
2
Isolation and properties of recombinant DNA produced variants of human alpha 1-proteinase inhibitor.人α1-蛋白酶抑制剂重组DNA产生变体的分离与特性
J Biol Chem. 1985 Apr 10;260(7):4384-9.